MedTrace Logo

Comparison of Creatinine Clearance Calculation for Estimation of GFR in Patients Receiving HD Methotrexate

NCT01319591 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2019-01-22

No results posted yet for this study

Summary

The purpose of this study is to compare different estimates of calculating creatinine clearance by mathematical formula and compare them to creatinine clearance based on a timed urine collection in patients who received high-dose methotrexate for the treatment of primary CNS lymphoma or CNS involvement of systemic lymphoma.

Conditions

  • CNS Lymphoma
  • CNS Involvement of Systemic Lymphoma

Sponsors & Collaborators

Principal Investigators

  • Audrea H Szabatura, PharmD, BCOP · Dana-Farber Cancer Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2014-08-31
Completion
2017-09-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01319591 on ClinicalTrials.gov